6,138
Views
22
CrossRef citations to date
0
Altmetric
Review Article

The bumpy road to achieve herd immunity in COVID-19

References

  • Drosten, C.; Günther, S.; Preiser, W.; van der Werf, S.; Brodt, H.-R.; Becker, S.; Rabenau, H.; Panning, M.; Kolesnikova, L.; Fouchier, R. A. M.; et al. Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome. New England Journal of Medicine. 2003, 348(20), 1967–1976.
  • Ksiazek, T. G.; Erdman, D.; Goldsmith, C. S.; Zaki, S. R.; Peret, T.; Emery, S.; Tong, S.; Urbani, C.; Comer, J. A.; Lim, W.; et al. A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome. N. Engl. J. Med. 2003, 348(20), 1953–1966.
  • Peiris, J. S.; Lai, S. T.; Poon, L. L.; Guan, Y.; Yam, L. Y.; Lim, W.; Nicholls, J.; Yee, W. K.; Yan, W. W.; Cheung, M. T.; et al. Coronavirus as a Possible Cause of Severe Acute Respiratory Syndrome. Lancet. 2003, 361, 1319–1325. DOI: 10.1016/S0140-6736(03)13077-2.
  • Webster, R. G.;. Wet Markets—a Continuing Source of Severe Acute Respiratory Syndrome and Influenza? Lancet. 2004, 363, 234–236. DOI: 10.1016/S0140-6736(03)15329-9.
  • Woo, P. C.; Kp Lau, S.; Yuen, K.-Y. Infectious Diseases Emerging from Chinese Wet-markets: Zoonotic Origins of Severe Respiratory Viral Infections. Curr. Opin. Infect. Dis. 2006, 19, 401–407. DOI: 10.1097/01.qco.0000244043.08264.fc.
  • Che, X. Y.; Di, B.; Zhao, G.-P.; Wang, Y.-D.; Li-W., Q.; Hao, W.; Wang, M.; Qin, P.-Z.; Liu, Y.-F.; Chan, K.-H.; et al. A Patient with Asymptomatic Severe Acute Respiratory Syndrome (SARS) and Antigenemia from the 2003–2004 Community Outbreak of SARS in Guangzhou, China. Clin. Infect. Dis. 2006, 43, e1–e5. DOI: 10.1086/504943.
  • Lau, S. K.; Woo, P. C.; Li, K. S.; Huang, Y.; Tsoi, H. W.; Wong, B. H.; Wong, S. S.; Leung, S. Y.; Chan, K. H.; Yuen, K. Y. Severe Acute Respiratory Syndrome Coronavirus-like Virus in Chinese Horseshoe Bats. Proc. Natl. Acad. Sci. USA. 2005, 102, 14040–14045. DOI: 10.1073/pnas.0506735102.
  • Li, W.; Shi, Z.; Yu, M.; Ren, W.; Smith, C.; Epstein, J. H.; Wang, H.; Crameri, G.; Hu, Z.; Zhang, H.; et al. Bats are Natural Reservoirs of SARS-like Coronaviruses. Science. 2005, 310, 676–679. DOI: 10.1126/science.1118391.
  • Wang, M.; Yan, M.; Xu, H.; Liang, W.; Kan, B.; Zheng, B.; Chen, H.; Zheng, H.; Xu, Y.; Zhang, E.; et al. SARS-CoV Infection in a Restaurant from Palm Civet. Emerg. Infect. Dis. 2005, 11, 1860–1865. DOI: 10.3201/eid1112.041293.
  • Cheng, V. C.; Lau, S. K.; Woo, P. C.; Yuen, K. Y. Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection. Clin. Microbiol. Rew. 2007, 20(4), 660–694.
  • https://www.worldometers.info/coronavirus/ ( accessed Aug 14).
  • Osborn, M.; Lucas, S.; Stewart, R.; Swift, B.; Youd, E. Briefing on COVID-19. Autopsy Practice Relating to Possible Cases of COVID-19. The Royal College of Pathologists, https://www.rcpath.org/uploads/assets/d5e28baf-5789-4b0f-acecfe370eee6223/fe8fa85a-f004-4a0c-81ee4b2b9cd12cbf/Briefing-on-COVID-19-autopsy-Feb-2020.pdf.
  • Carvalho, M. S.; Freitas, L. P.; Cruz, O. G.; Brasil, P.; Bastos, L. S. Association of past Dengue Fever Epidemics with the Risk of Zika Microcephaly at the Population Level in Brazil. Sci. Rep. 2020, 10, 1752. DOI: 10.1038/s41598-020-58407-7.
  • Bandyopadhyay, A. S.; Macklin, G. R. Final Frontiers of the Polio Eradication Endgame. Curr. Opin. Infect. Dis. 2020, 33(5), 404–410. DOI: 10.1097/QCO.0000000000000667.
  • Kirtimaan, S.;. COVID-19: Herd Immunity and Convalescent Plasma Transfer Therapy. J. Med. Virol. 2020. DOI: 10.1002/jmv.25870.
  • Heffernan, J. M.; Smith, R. J.; Wahl, L. M. Perspectives on the Basic Reproductive Ratio. J. R. Soc. Interface. 2005, 2(4), 281–293. DOI: 10.1098/rsif.2005.0042.
  • Biggerstaff, M.; Cauchemez, S.; Reed, C.; Gambhir, M.; Finelli, L. Estimates of the Reproduction Number for Seasonal, Pandemic, and Zoonotic Influenza: A Systematic Review of the Literature. BMC Infect. Dis. 2014, 14, 480. DOI: 10.1186/1471-2334-14-480.
  • Liu, Y.; Gayle, A. A.; Wilder-Smith, A.; Rocklov, J. The Reproductive Number of COVID-19 Is Higher Compared to SARS Coronavirus. J. Travel Med. 2020, 27(2), taaa021. DOI: 10.1093/jtm/taaa021.
  • Zhao, S.; Cao, P.; Gao, D.; Zhuang, Z.; Cai, Y.; Ran, J.; Chong, M. K. C.; Wang, K.; Lou, Y.; Wang, W.; et al. Serial Interval in Determining the Estimation of Reproduction Number of the Novel Coronavirus Disease (COVID-19) during the Early Outbreak. J. Travel Med. 2020, 27(3), taaa033. DOI: 10.1093/jtm/taaa033.
  • Garnett, G. P.;. Role of Herd Immunity in Determining the Effect of Vaccines against Sexually Transmitted Disease. J. Infect. Dis. 2005, 191(Suppl 1), S97–106. PMID 15627236. DOI: 10.1086/425271.
  • Thompson, R. N.; Hollingsworth, T. D.; Isham, V.; Arribas-Bel, D.; Ashby, B.; Britton, T.; Challenor, P.; Chappel, L. H. K.; Clapham, H.; Cunniffe, N. J.; et al. Key Questions for Modelling COVID-19 Exit Strategies, Key Questions for Modelling COVID-19 Exit Strategies. Proc. R. Soc. B 2020, 287, 20201405. DOI: 10.1098/rspb.2020.1405.
  • Mallory, M. L.; Lindesmith, L. C.; Baric, R. S. Vaccination-induced Herd Immunity: Successes and Challenges. J. Allergy Clin. Immunol. 2018, 142, 64–66. DOI: 10.1016/j.jaci.2018.05.007.
  • Rokni, M.; Ghasemi, V.; Tavakoli, Z. Immune Responses and Pathogenesis of SARS-CoV-2 during an Outbreak in Iran: Comparison with SARS and MERS. Rev. Med. Virol. 2020, 30, e2107. DOI: 10.1002/rmv.2107.
  • Papachristodoulou, E., .; Kakoullis, L.; Parperis, K., .; Panos, G. Long-term and Herd Immunity against SARS-CoV-2: Implications from Current and past Knowledge. Pathog. Dis. 2020, 78, ftaa025. DOI: 10.1093/femspd/ftaa025.
  • Snyder, T. M.; Gittelman, R. M.; Klinger, M.; May, D. H.; Osborne, E. J.; Taniguchi, R.; Zahid, H. J.; Kaplan, I. M.; Dines, J. N.; Noakes, M. N.; et al. Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels. medRxiv. 2020, 4. DOI: 10.1101/2020.07.31.20165647.
  • Kissler, S. M.; Tedijanto, C.; Goldstein, E., .; Grad, Y. H.; Lipsitch, M. Projecting the Transmission Dynamics of SARS-CoV-2 through the Postpandemic Period. Science. 2020, 368, 860–868. DOI: 10.1126/science.abb5793.
  • Wolfel, R.; Corman, V. M.; Guggemos, W.; Seilmaier, M.; Zange, S.; Müller, M. A.; Niemeyer, D.; Jones, T. C.; Vollmar, P.; Rothe, C.; et al. Virological Assessment of Hospitalized Patients with COVID-2019. Nature 2020, 581, 465–469. DOI: 10.1038/s41586-020-2196-x.
  • Zhao, J.; Yuan, Q.; Wang, H.; Liu, W.; Liao, X.; Su, Y.; Wang, X.; Yuan, J.; Li, T.; Li, J.; et al. Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019. Clin. Infect. Dis. 2020, ciaa344. DOI: 10.1093/cid/ciaa344.
  • Wu, F.; Wang, A.; Liu, M.; Wang, Q.; Chen, J.; Xia, S.; Ling, Y.; Yuling Zhang, Y.; Xun, J.; Lu, L.; et al. Neutralizing Antibody Responses to SARS-CoV-2 in a COVID-19 Recovered Patient Cohort and Their Implications. medRxiv. 2020. DOI: 10.1101/2020.03.30.20047365.
  • Li, X.; Zhang, Z.; Zong, Z. A Case of A Readmitted Patient Who Recovered from COVID-19 in Chengdu. Crit. Care. 2020, 24, 8–10. DOI: 10.1186/s13054-020-02877-8.
  • Lan, L.; Xu, D.; Ye, G.; Xia, C.; Wang, S.; Li, Y.; Xu, H. Positive RT-PCR Test Results in Patients Recovered from COVID-19. JAMA. 2020, 323, 1502–1503. DOI: 10.1001/jama.2020.2783.
  • Wang, M.; Li, M.; Ren, R.; Li, L.; Chen, E.-Q.; Weimin Li, W.; Binwu Ying, B. International Expansion of a Novel SARS-CoV-2 Mutant. J. Virol. 2020, 94, e00567–20. DOI: 10.1128/JVI.00567-20.
  • Biswas, A.; Bhattacharjee, U.; Chakrabarti, A. K.; Tewari, D. N.; Banu, H.; Dutta, S. Emergence of Novel Coronavirus and COVID-19: Whether to Stay or Die Out? Crit. Rev. Microbiol. 2020, 1–12.
  • Korber, B.; Fischer, W. M.; Gnanakaran, W. M.; Yoon,H., S.; Theiler, J.; Abfalterer, W.; Hengartner, N.; Giorgi, E. E.; Bhattacharya, T.; Foley, B.; et al. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell. 2020, 182(4), 812–827.e19. DOI: 10.1016/j.cell.2020.06.043.
  • Pascal, K. E.; Dudgeon, D.; Trefry, J. C.; Anantpadma, M.; Sakurai, Y.; Murin, C. D.; Turner, H. L.; Fairhurst, J.; Torres, M.; Rafique, A.; et al. Development of Clinical-Stage Human Monoclonal Antibodies that Treat Advanced Ebola Virus Disease in Nonhuman Primates. J. Infect. Dis. 2018, 218(suppl_5), S612–S626.
  • Zhou, D.; Duyvesteyn, H. M. E.; Chen, C.-P.; Huang, C.-G.; Chen, T.-H.; Shih, S.-R.; Lin, Y.-C.; Cheng, C.-Y.; Cheng, S.-H.; Huang, Y.-C.; et al. Structural Basis for the Neutralization of SARS-CoV-2 by an Antibody from a Convalescent Patient. Nat. Struct. Mol. Biol. 2020 Jul 31. Online ahead of print. DOI: 10.1038/s41594-020-0480-y.
  • Shanmugaraj, B.; Siriwattananon, K.; Wangkanont, K.; Phoolcharoen, W. Review Perspectives on Monoclonal Antibody Therapy as Potential Therapeutic Intervention for Coronavirus Disease-19 (COVID-19). Asian Pac J. Allergy Immunol. 2020, 38(1), 10–18.
  • Brouwer, P. J. M.; Caniels, T. G.; van der Straten, K.; Snitselaar, J. L.; Aldon, Y.; Bangaru, S.; Torres, J. L.; Okba, N. M. A.; Claireaux, M.; Kerster, G.; et al. Potent Neutralizing Antibodies from COVID-19 Patients Define Multiple Targets of Vulnerability. Science. 2020, 369(6504), 643–650. Epub 2020 Jun 15. DOI: 10.1126/science.abc5902.
  • La Maestra, S.; Abbondandolo, A.; De Flora, S. Epidemiological Trends of COVID-19 Epidemic in Italy during March 2020. From 1,000 to 100,000 Cases. J. Med. Virol. 2020, 92(10), 1956–1961. DOI: 10.1002/jmv.25908.
  • Wissel, B. D.; Van Camp, P. J.; Kouril, M.; Weis, C.; Glauser, T. A.; White, P. S.; Kohane, I. S.; Judith, W.; Dexheimer, J. W. An Interactive Online Dashboard for Tracking COVID-19 in U.S. Counties, Cities, and States in Real Time. J. Am. Med. Inform. Assoc. 2020, 27(7), 1121–1125. DOI: 10.1093/jamia/ocaa071.
  • Hunter, D. J.;. Covid-19 and the Stiff Upper Lip—The Pandemic Response in the United Kingdom. N. Engl. J. Med. 2020, 382, e31. DOI: 10.1056/NEJMp2005755.
  • Horton, R.;. Offline: COVID-19—a Reckoning. Lancet (London, England). 2020, 395(10228), 935. DOI: 10.1016/S0140-6736(20)30669-3.
  • Brett, T. S.; Rohani, P. COVID-19 Herd Immunity Strategies: Walking an Elusive and Dangerous Tightrope. medRxiv. 2020. DOI: 10.1101/2020.04.29.20082065.
  • Verity, R.; Okell, L. C.; Dorigatti, I.; Winskill, P.; Whittaker, C.; Imai, N.; Cuomo-Dannenburg, G.; Thompson, H.; Walker, P. G. T.; Fu, H.; et al. Estimates of the Severity of Coronavirus Disease 2019: A Model-based Analysis. Lancet Infect Dis. 2020, 20(6), 669–677. DOI: 10.1016/S1473-3099(20)30243-7.
  • Guan, W. J.; Ni, Z. Y.; Hu, Y.; Liang, W. H.; Ou, C. Q.; He, J. X.; Liu, L.; Shan, H.; Lei, C.-L.; Hui, D. S. C.; et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020, 382(18), 1708–1720. DOI: 10.1056/NEJMoa2002032.
  • Zhou, F.; Yu, T.; Du, R.; Fan, G.; Liu, Y.; Liu, Z.; Xiang, J.; Wang, Y.; Song, B.; et al. Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet. 2020, 395(10229), 1054–1062.
  • Bi, Q.; Wu, Y.; Mei, S.; Ye, C.; Zou, X.; Zhang, Z.; Liu, X.; Wei, L.; Truelove, S. A.; Zhang, T.; et al. Epidemiology and Transmission of COVID-19 in 391 Cases and 1286 of Their Close Contacts in Shenzhen, China: A Retrospective Cohort Study. Lancet 2020, 20, 911–919. DOI: 10.1016/S1473-3099(20)30287-5.
  • Goldstein, E.; Lipsitch, M. Temporal Rise in the Proportion of Both Younger Adults and Older Adolescents among COVID-19 Cases in Germany: Evidence of Lesser Adherence to Social Distancing Practices? medRxiv. 2020. DOI: 10.1101/2020.04.08.20058719.
  • Killerby, M. E.; Biggs, H. M.; Haynes, A.; Dahl, R. M.; Mustaquim, D.; Gerber, S. I.; Watson, J. T. Human Coronavirus Circulation in the United States 2014–2017. J. Clin. Virol. 2018, 101, 52–56. DOI: 10.1016/j.jcv.2018.01.019.
  • Duggan, N. M.; Ludy, S. M.; Shannon, B. C.; Reisner, A. R.; Wilcox, S. R. Is Novel Coronavirus 2019 Reinfection Possible? Interpreting Dynamic SARS-CoV-2 Test Results through a Case Report. Am. J. Emerg. Med. 2020, [Epub ahead of print]. DOI: 10.1016/j.ajem.2020.06.079.
  • Antia, A.; Ahmed, H.; Handel, A.; Carlson, N. E.; Amanna, I. J.; Antia, R.; Slifka, M. Heterogeneity and Longevity of Antibody Memory to Viruses and Vaccines. PLoS Biol. 2018, 16(8), e2006601. DOI: 10.1371/journal.pbio.2006601.
  • Orlowski, E. J. W.; Goldsmith, D. J. A. Four Months into the COVID-19 Pandemic, Sweden’s Prized Herd Immunity Is Nowhere in Sight. J. R. Soc. Med. 2020, 113(8), 292–298. DOI: 10.1177/0141076820945282.
  • Griffin, S.;. Covid-19: Herd Immunity Is “Unethical and Unachievable,” Say Experts after Report of 5% Seroprevalence in Spain. BMJ. 2020, 370, m2728. DOI: 10.1136/bmj.m2728.
  • Gudbjartsson, D. F.; Norddahl, G. L.; Melsted, P.; Gunnarsdottir, K.; Holm, H.; Eythorsson, E.; Arnthorsson, A. O.; Helgason, D.; Bjarnadottir, K.; Ingvarsson, R. F.; et al. Humoral Immune Response to SARS-CoV-2 in Iceland. NEJM.org. 2020. DOI: 10.1056/NEJMoa2026116.
  • World Health Organisation. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19-11. March 2020 [Internet]. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020.
  • Pueyo, T.; Coronavirus: The Hammer and the Dance. https://medium.com/@tomaspueyo/coronavirus-the-hammer-andthe-dance-be9337092b56 2020.
  • Assenza, T.; Collard, F.; Dupaigne, M.; Fève, P.; Hellwig, C.; Kankanamge, S.; Werquin, N. The Hammer and the Dance: Equilibrium and Optimal Policy during a Pandemic Crisis. CEPR Discussion Paper 14731, 2020.
  • Jung, F.; Krieger, V.; Hufert, F. T.; Kupper, J.-H. How We Should Respond to the Coronavirus SARS-CoV-2 Outbreak: A German Perspective. Clin. Hemorheol. Microcirc. 2020, 7, 4363–4372. DOI: 10.3233/CH-209004.
  • Sartor, G.; Del Riccio, M.; Dal Poz, I.; Bonanni, P.; Bonaccorsi, G. COVID-19 in Italy: Considerations on Official Data. Int. J. Infect. Dis. 2020, 9, 8188–8190.
  • Rodriguez-Morales, A. J.; Cardona-Ospina, J. A.; Gutiérrez-Ocampo, E.; Villamizar-Peña, R.; Holguin-Rivera, Y.; Escalera-Antezana, J. P.; Alvarado-Arnez, L. E.; Bonilla-Aldana, D. K.; Franco-Paredes, C.; Henao-Martinez, A. F.; et al. Clinical, Laboratory and Imaging Features of COVID-19: A Systematic Review and Meta-analysis. Travel Med. Infect. Dis. 2020, 34, 101623. DOI: 10.1016/j.tmaid.2020.101623.
  • Nitulescu, G. M.; Paunescu, H.; Moschos, S. A.; Petrakis, D.; Nitulescu, G.; Ion, G. N. D.; Spandidos, D. A.; Nikolouzakis, T. K.; Nikolaos Drakoulis, N.; Tsatsakis, A. Comprehensive Analysis of Drugs to Treat SARS-CoV-2 Infection: Mechanistic Insights into Current COVID-19 Therapies (Review). Int. J. Mol. Med. 2020, 46(2), 467–488. DOI: 10.3892/ijmm.2020.4608.
  • https://www.gavi.org/vaccineswork/covid-19-vaccine-race
  • Neagu, M.; Baicus, C.; Zurac, S. Pandemia Actuală – Back to the Future? Politici De Sanatate. 2020. https://www.politicidesanatate.ro/pandemia-actuala-back-to-the-future/
  • https://www.webmd.com/lung/news/20200610/covid-19-latest-updates
  • Daniela, C.; Hartung, T.; Docea, A. O.; Spandidos, D. A.; Egorov, A. M.; Shtilman, M. I.; Carvalho, F.; Tsatsakis, A. COVID-19 Vaccines: Ethical Framework Concerning Human Challenge Studies. DARU J. Pharm. Sci. DOI: 10.1007/s40199-020-00371-8.
  • Halstead, S. B.;. Dengvaxia Sensitizes Seronegatives to Vaccine Enhanced Disease Regardless of Age. Vaccine. 2017, 35, 6355–6358. DOI: 10.1016/j.vaccine.2017.09.089.
  • Santos, T. G.; Pharma Firm Issues Caution on Use of Anti-dengue Vaccine. 2017. https://technology.inquirer.net/69907/pharma-firm-issues-caution-anti-dengue-vaccine-sanofi-dengvaxia-vaccine-health-dengue.
  • Fatima, K.; Syed, N. I. Dengvaxia Controversy: Impact on Vaccine Hesitancy. J. Glob. Health. 2018, 8. DOI: 10.7189/jogh.08.020312.
  • Jiang, S.;. Don’t Rush to Deploy COVID-19 Vaccines and Drugs without Sufficient Safety Guarantees. Nature. 2020, 579, 321. DOI: 10.1038/d41586-020-00751-9.
  • Iwasaki, A.; Yang, Y. The Potential Danger of Suboptimal Antibody Responses in COVID-19. Nat. Rev. Immunol. 2020, 20, 1–3. DOI: 10.1038/s41577-020-0321-6.
  • Negro, F.;. Is Antibody-dependent Enhancement Playing a Role in COVID-19 Pathogenesis? Swiss Med. Wkly. 2020, 150, w20249.
  • Coish, J. M.; MacNeil, A. J. Out of the Frying Pan and into the Fire? Due Diligence Warranted for ADE in COVID-19. Microbes Infect. 2020 Jun 24. [Epub ahead of print]. DOI: 10.1016/j.micinf.2020.06.006.
  • Constantin, C.; Neagu, M.; Supeanu, T.; Chiurciu, V.; Spandidos, D. A. IgY - Turning the Page toward Passive Immunization in COVID-19 Infection. Exp. Ther. Med. 2020, 20(1), 151–158. https://www.spandidos-publications.com/10.3892/etm.2020.8704.
  • Kostoff, R. N.; Briggs, M. B.; Porter, A. L.; Michael Aschner, M.; Spandidos, D. A.; Tsatsakis, A. COVID-19: Post-lockdown Guidelines. Int. J. Mol. Med. 2020, 46(2), 463–466. DOI: 10.3892/ijmm.2020.4640.
  • Neagu, M.; Constantin, C.; Popescu, I. D.; Zipeto, D.; Tzanakakis, G.; Nikitovic, D.; Fenga, C.; Stratakis, C. A.; Spandidos, D. A.; Tsatsakis, A. M. Inflammation and Metabolism in Cancer Cell – Mitochondria Key Player. Front. Oncol. 2019, 9, 348. DOI: 10.3389/fonc.2019.00348.
  • Neagu, M.;. Metabolic Traits in Cutaneous Melanoma. Front. Oncol. 2020, 10, 851. DOI: 10.3389/fonc.2020.00851.
  • Neagu, M.; Constantin, C.; Caruntu, C.; Dumitru, C.; Surcel, M.; Zurac, S. Inflammation – Key Process in Skin Tumorigenesis. Oncol. Lett. 2019, 17, 4068–4084. DOI: 10.3892/ol.2018.9735.
  • Neagu, M.; Constantin, C.; Longo, C. Chemokines in the Melanoma Metastasis Biomarkers Portrait. J Immunoassay Immunochem, 2015. 36(6):559-66. https://doi.org/10.3892/ol.2018.9735.
  • Solomon, I.; Voiculescu, V. M.; Caruntu, C.; Lupu, M.; Popa, A.; Ilie, M. A.; Albulescu, R.; Caruntu, A.; Tanase, C.; Constantin, C.; et al. Neuroendocrine Factors and Head and Neck Squamous Cell Carcinoma – An Affair to Remember. Dis. Markers. 2018, 2018, Article ID 9787831. DOI: 10.1155/2018/9787831.
  • Tzanakakis, G.; Giatagana, E.-M.; Kuskov, A.; Berdiaki, A.; Tsatsakis, A. M.; Neagu, M.; Nikitovic, D. Proteoglycans in the Pathogenesis of Hormone-dependent Cancers: Mediators and Effectors. Cancers. 2020, 12(9), E2401. DOI: 10.3390/cancers12092401.
  • Alberto, B.;. Obesity, Inflammation and COVID-19. Swiss Med. Wkly. 2020, 150, w20349. DOI: 10.4414/smw.2020.20349.
  • Popa, M.-L.; Albulescu, R.; Neagu, M.; Hinescu, M. E.; Tanase, C. Multiplex Assay for Multiomics Advances in Personalized-precision Medicine. J. Immunoassay Immunochem. 2019, 40, 3–25. Published online: 11 Jan 2019. DOI: 10.1080/15321819.2018.156294.
  • Liu, J.; Li, S.; Liu, J.; Liang, B.; Wang, X.; Wang, H.; Li, W.; Tong, Q.; Yi, J.; Zhao, L.; et al. Longitudinal Characteristics of Lymphocyte Responses and Cytokine Profiles in the Peripheral Blood of SARS-CoV-2 Infected Patients. EBioMedicine. 2020, 55, 102763. DOI: 10.1016/j.ebiom.2020.102763.
  • Del Valle, D. M.; Kim-Schulze, S.; Huang, -H.-H.; Beckmann, N. D.; Nirenberg, S.; Wang, B.; Lavin, Y.; Swartz, T. H.; Madduri, D.; Stock, A.; et al. An Inflammatory Cytokine Signature Predicts COVID-19 Severity and Survival. Nat. Med. 2020. DOI: 10.1038/s41591-020-1051-9.
  • Xu, X.; Han, M.; Li, T.; Sun, W.; Wang, D.; Fu, B.; Zhou, Y.; Zheng, X.; Yang, Y.; Li, X.; et al. Effective Treatment of Severe COVID-19 Patients with Tocilizumab. Proc. Natl Acad. Sci. USA. 2020, 117, 10970–10975. DOI: 10.1073/pnas.2005615117.
  • Gritti, G.; Raimondi, F.; Ripamonti, D.; Riva, I.; Landi, F.; Alborghetti, L.; Frigeni, M.; Damiani, M.; Micò, C.; Fagiuoli, S.; et al. IL-6 Signalling Pathway Inactivation with Siltuximab in Patients with COVID-19 Respiratory Failure: An Observational Cohort Study. medRxiv. 2020. DOI: 10.1101/2020.04.01.20048561.
  • Ledford, H.;. Coronavirus Breakthrough: Dexamethasone Is First Drug Shown to Save Lives. Nature. 2020, 582, 469. DOI: 10.1038/d41586-020-01824-5.
  • Surcel, M.; Constantin, C.; Caruntu, C.; Zurac, S.; Neagu, M. Inflammatory Cytokine Pattern Is Sex-dependent in Mouse Cutaneous Melanoma Experimental Model. J. Immunol. Res. 2017, 2017, Article ID 9212134, 1–10. DOI: 10.1155/2017/9212134.
  • Zeng, Z.; Yu, H.; Chen, H.; Qi, W.; Chen, L.; Chen, G.; Yan, W.; Chen, T.; Ning, Q.; Han, M.; et al. Longitudinal Changes of Inflammatory Parameters and Their Correlation with Disease Severity and Outcomes in Patients with COVID-19 from Wuhan, China. Crit. Care. 2020, 24(1), 525. DOI: 10.1186/s13054-020-03255-0.